MD PhD Opportunity in Urinary Tract Infections with a Focus on phage Therapy February 17, 2025 Balgrist University Hospital, Zurich has an academic translational research group for phage therapy which is led by the microbiologist/clinician team of Dr. Shawna McCallin,…
PhD or Post-Doc in Bacteriophage Engineering February 11, 2025 The Loris lab has 25 years of expertise in molecular microbiology via the study of bacterial toxin-antitoxin systems and has recently shifted its interest to include…
PhD Opportunity in Characterisation of the Biological Features of Phages through Large-Scale Analyses December 18, 2024 The project represents an ambitious attempt to delve into this universe of uncharacterised biodiversity through a series of sequential investigations. The first step will…
Opportunity to work on developing biosensors to detect phage replication December 17, 2024 When phages kill bacteria, they cause changes in the bacterial membrane that can be detected using electrical impedance spectroscopy. This project aims to develop…
Opportunity to work as a Senior Scientist, NextGen Sequencing (NGS) Assay Development for Crawford Lab December 14, 2024 The lab of Jeremy Chase Crawford in the Department of Host-Microbe Interactions is seeking a highly skilled Sr. Scientist to develop and implement novel…
PhD in undertsanding how antibiotics and bacterial defence systems interact to limit antibiotic resistance transmission December 12, 2024 This project will investigate how AMR plasmids, bacterial defenses, and antibiotic treatment interact to determine the overall spread of AMR plasmids. To do this,…
PhD opportunity to work on Combinations of bacteriophages and cold plasma for biofilm biocontrol December 4, 2024 The ongoing antimicrobial resistance crisis has incentivised research into alternative antibacterial and antibiofilm agents. One of them is cold plasma and plasma-activated water (PAW),…
PhD Opportunity in using experimental evolution to understand the impact of phage therapy on Clostridioides difficile December 1, 2024 C. difficile is intrinsically resistant to many antibiotics and thrives in the disrupted gut environment created by antibiotic treatment. C. difficile is a spore-forming…
PhD Opportunity to work on efficacy of phage cocktails for eradicating MDR E.coli from the GI tract of colonised livestock species November 29, 2024 Examples of common E. coli bacterial diseases include colibacillosis in chickens and swine caused by avian pathogenic E. coli (APEC) and enterotoxigenic E. coli…
PhD Opportunity to work on selection and optimization of phage therapy for treating chronic infections November 14, 2024 This research aims to create phage treatments that are highly effective in complex, infection-like environments while minimizing immunogenicity, offering new hope for patients with…